Kolexia
Benderra Marc-Antoine Oncologie médicale
Benderra Marc-Antoine
Oncologie médicale
Hôpital Tenon
Paris, France
131 Activités
535 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein COVID-19 Tumeurs du poumon Carcinomes Tumeurs de la prostate Métastase tumorale Tumeurs de l'appareil digestif Cellules tumorales circulantes Tumeurs colorectales

Collaborateurs

Voir plus
Gligorov Joseph
Gligorov Joseph
Hôpital Tenon, Paris, France
Prebet Coralie
Prebet Coralie
Hôpital Tenon, Paris, France
Khalil Ahmed
Khalil Ahmed
Hôpital Tenon, Paris, France
Akla Sarra
Akla Sarra
Centre hospitalier de Versailles, Le Chesnay, France

Industries

Voir plus
Novartis
19 collaboration(s)
Dernière en 2023
Lilly
16 collaboration(s)
Dernière en 2023
B3TSI
14 collaboration(s)
Dernière en 2023
Daiichi Sankyo
6 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence
Essai Clinique (Lilly)   29 février 2024
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.
Bulletin du cancer   16 décembre 2023
FREDO-ODX-23: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Essai Clinique (CHU Besançon)   14 décembre 2023
Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.
Cancer medicine   01 novembre 2023
Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study.
ESMO open   11 octobre 2023
463P Impact of two waves of Sars-Cov-2 outbreak on the clinical presentation and outcomes of newly referred breast cancer cases at AP-HP: A retrospective multicenter cohort study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Les traitements médicamentaux avec le Dr Marc Benderra
Youtube @ Resilience   13 juillet 2023
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.
Oncogene   06 juin 2023
189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-BREAST01)
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023
The 10-month mortality rate among older patients treated for digestive system cancer during the first wave of the COVID-19 pandemic: The CADIGCOVAGE multicentre cohort study.
Journal of geriatric oncology   27 janvier 2023